Virtual Diabetes Care:Unlocking the Keys to Real Results

Managing the care of people with diabetes is costly and time intensive, especially for our nation's primary care providers who shoulder 80% of that responsibility. Virtual care programs have the potential to fill critical gaps and meet increasing demands, but can they produce real results?

This webinar explores the keys to augmenting traditional brick-and-mortar care with virtual care for people with diabetes.

You will learn:

The model for a successful virtual care program, including the combination of connected diabetes technologies and care management services.
Why insulin therapy optimization is a mission critical element.
How A1C and time in range play a central role in value-based reimbursement.
Evidence surrounding the clinical and economic impacts of A1C and hypoglycemia.
The benefits to patients and providers when traditional care is augmented by virtual care, and how both groups are responding to virtual care.
Real-world data showing sustained A1C reductions of 2.7% points and higher.

Ronald Dixon, MD, MA

Head of Clinical Affairs and President of Physician Group
Onduo

Bio info: Dr. Ronald Dixon is head of clinical affairs and president of the physician group at Onduo, a joint venture of...

Dr. Ronald Dixon is head of clinical affairs and president of the physician group at Onduo, a joint venture of Sanofi and Verily (an Alphabet company) that combines sensors, software and people to deliver diabetes care to individuals across the United States. Prior to joining Onduo, Dr. Dixon served in multiple roles at Massachusetts General Hospital, including director of the Virtual Practice Project, director of the Center for the Integration of Medicine and Innovative Technology (CIMIT) Delivery System Innovation Program, and medical director for Network Development. He was also a project director for the Massachusetts General Physicians Organization, assistant professor of medicine at Harvard Medical School, and medical staff for the Boston Red Sox. Dr. Dixon received a doctorate degree from Dartmouth College Geisel School of Medicine. He completed a residency at Massachusetts General Hospital and administrative fellowship with the Massachusetts General Physicians Organization. Over his career, Dr. Dixon has led multiple initiatives focused on telemedicine and other alternative methods of care delivery, and has directed the development of scalable solutions and applications for population health, chronic disease management and disease prevention. Among his many projects: virtual visits in general medicine, primary care kiosks, low acuity clinics, and remote physiological monitoring. He has also participated on several committees aimed at making care delivery more efficient and effective for patients, providers and health systems.

Andrew Rhinehart, MD, FACP, FACE, CDE, BC-ADM

Chief Medical Officer
Glytec

Bio info: Dr. Andrew Rhinehart is chief medical officer at Glytec, an enterprise software company specializing in solutions...

Dr. Andrew Rhinehart is chief medical officer at Glytec, an enterprise software company specializing in solutions for diabetes therapy management and medication optimization. Prior to joining Glytec in 2015, Dr. Rhinehart was in clinical practice for 20 years, and for seven years, served as program director and diabetologist at Johnston Memorial Diabetes Care Center in Abington, Virginia, now part of Ballad Health, the region's largest health system. Dr. Rhinehart received a doctorate degree from the University of Maryland School of Medicine and completed a residency at East Tennessee State University. Although trained in internal medicine, Dr. Rhinehart was inducted as a fellow of the American College of Endocrinology based on his expertise in the field of diabetology. He is a current member and past chair of the American Diabetes Association’s Primary Care Advisory Group and has served previously on their Professional Practice and Prevention Committees. Dr. Rhinehart was the first physician board certified in advanced diabetes management (BC-ADM); he serves as a content expert for the BC-ADM Exam and sits on the BC-ADM Exam Oversight Committee. He is also a certified diabetes educator. Dr. Rhinehart has been awarded recognition from the National Committee for Quality Assurance Diabetes Physician Recognition program for providing high quality care to persons with diabetes from 2002 until leaving clinical practice in 2015. He participated on the 2012 and 2017 National Standards for Diabetes Self-Management Education and Support revision workgroups.